Zagorodnikova Goryachkina K, Burbello A, Sychev D, Frolov M, Kukes V, Petrov V. Clinical pharmacology in Russia-historical development and current state. Eur J Clin Pharmacol. 2015;71(2):159-63.
doi: 10.1007/s00228-014-1787-6.
- Автор: Виталий Цветов
- Просмотров: 8018
Sychev DA, Zastrozhin MS, Smirnov VV, Grishina EA, Savchenko LM, Bryun EA. The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction. Pharmgenomics Pers Med. 2016;9:89–95.
doi: 10.2147/PGPM.S110385
- Автор: Виталий Цветов
- Просмотров: 7119
Zastrozhin MS, Smirnov VV, Sychev DA, Savchenko LM, Bryun EA, Matis OA. CYP3A4 activity and haloperidol effects in alcohol addicts. Int J Risk Saf Med. 2015;27 Suppl 1:S23-4.
doi: 10.3233/JRS-150676.
- Автор: Виталий Цветов
- Просмотров: 7098
Mirzaev K, Sychev D, Arutyunyan G, Yugay A, Andreev D. Cytochrome 2C19 Enzyme Polymorphism Frequency in Different Indigenous Ethnic Groups in Russian Federation: A Systematic Review J Pharmacogenomics Pharmacoproteomics 2014 5:136.
doi: 10.4172/2153-0645.1000136
- Автор: Виталий Цветов
- Просмотров: 6994
Sychev DA, Malova EU. Evidence-based pharmacogenetics: Is it possible? Int J Risk Saf Med. 2015;27 Suppl 1:S97-8.
doi: 10.3233/JRS-150706.
- Автор: Виталий Цветов
- Просмотров: 7076
Страница 8 из 9
